Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

New opioid analgesics from Astra

Sep. 11, 1997

SAR reported by Parke-Davis for series of N-type Ca2+ antagonists

Sep. 10, 1997

Tachykinin receptor antagonists developed at Janssen

Sep. 10, 1997

(S)-(-)-OSU-6162 effective in monkey model of Parkinson's disease

Sep. 9, 1997

SB-204269, an anticonvulsant with a unique mechanism of action

Sep. 9, 1997

Copaxone approved in Canada

Sep. 9, 1997

Ethnic differences in codeine's efficacy/side effects

Sep. 9, 1997

Warner-Lambert/CoCensys develop neuroprotective agents

Sep. 9, 1997

Additional results for Bradycor in traumatic brain injury

Sep. 9, 1997

NK1 antagonist effective in rat model of focal cerebral ischemia

Sep. 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Asia
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...